Prognostic criteria in macular histoplasmic choroiditis.
作者信息
Kaider R J, Torsch T, O'Connor P R
出版信息
Int Ophthalmol Clin. 1975 Fall;15(3):41-9. doi: 10.1097/00004397-197501530-00008.
Abstract
- Fifty percent of 22 patients "desensitized" to histoplasmin developed subsequent activity, as compared to 44% of 23 patients without "desensitization." 2. Prednisone-induced remission of subclinical activity in patients monitoring their own central fields appears to be the most rewarding therapy for these desperate patients.
摘要
Zotero 插件